Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli
Crossref DOI link: https://doi.org/10.1186/s12879-017-2502-x
Published Online: 2017-06-07
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Seo, Yu Bin
Lee, Jacob
Kim, Young Keun
Lee, Seung Soon
Lee, Jeong-a
Kim, Hyo Youl
Uh, Young
Kim, Han-Sung
Song, Wonkeun
Funding for this research was provided by:
Ministry of Health & Welfare, Republic of Korea (HI12C0756)
